- “FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer” (Press release issued by FDA, FDA.gov)
- “FDA tries to speed access to Protalix Gaucher drug” (Reuters)
- “Sanofi-aventis Unveils Lantus Study Results” (Pharmaceutical Business Review)
- “NMT Medical Cuts Q2, FY09 Revenue View” (RTT News)
- “Spectrum Pharma Shares Drop As FDA Seeks More Zevalin Info” (The Wall Street Journal)
- “Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort” (Press release issued by Coapt Systems, Inc., PRNewsWire)
- “Oxford Bio says FDA supports TroVax plans” (Reuters)
- “Study Suggests Caffeine May Prevent Alzheimer’s Symptoms” (AHN News)
- “Johnson & Johnson Completes Initial Tender Offer For Cougar Biotechnology” (Press Release issued by Johnson & Johnson and Cougar Biotechnology, Medical News Today)
THE LATEST WORD
Top Industry Stories – July 6, 2009
Posted on July 6th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics